Sort
25,944 grants matching “neurodegeneration”
Targeting ApoE4 as a Therapeutic Strategy for Alzheimer's Disease
$818,590Robert W. Mahley · J. David Gladstone Institutes · U01 · FY2013 · AG
Neuroimmune Genomic Profiling of Alzheimer's Disease
$818,578Evgeny I Rogaev · Univ Of Massachusetts Med Sch Worcester · U01 · FY2025 · AG
MIF Nuclease actions in Synuclein Dementias
$818,421Valina L. Dawson · Johns Hopkins University · R01 · FY2024 · AG
Subjective Cognitive Decline in OIder Adults
$818,031Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2024 · AG
Robust detection of atrophy over short intervals in AD and FTLD
$817,999Bradford C Dickerson · Massachusetts General Hospital · R01 · FY2025 · AG
Neuroprotective Effects of Diadenosine Polyphosphates and antioxidant in the CNS
$817,880Yun Wang · National Institute On Drug Abuse · Z01 · FY2007 · DA
FEMALE REPRODUCTIVE AGING: THE ROLE OF ESTROGEN
$817,618University Of California Davis · P01 · FY2004 · AG
Characterization of the spatial and temporal response to tau in chronic traumatic encephalopathy
$817,484Jonathan D Cherry · Boston University Medical Campus · R01 · FY2025 · AG
Cognitive heterogeneity in those with high Alzheimer's Disease Risk
$817,404Rhoda Au · Boston University Medical Campus · R01 · FY2025 · AG
Regulation of the Endo/Lysosomal pathway
$817,399Rosa Puertollano · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's Disease
$817,317Yadong Huang · J. David Gladstone Institutes · R01 · FY2022 · AG
Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's Disease
$817,317Yadong Huang · J. David Gladstone Institutes · R01 · FY2024 · AG
Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's Disease
$817,317Yadong Huang · J. David Gladstone Institutes · R01 · FY2023 · AG
Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's Disease
$817,317Yadong Huang · J. David Gladstone Institutes · R01 · FY2021 · AG
TARGETING APOE BIOENERGETICS FOR REDUCING THE RISK OF NEURODEGENERATION AFTER CHRONIC TRAUMATIC BRAIN INJURY
$817,200The Roskamp Institute, Inc. · · FY2024 · Defense Health Agency
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
$817,176Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2022 · AG
Changes across the lifespan in the use of heuristics to guide decision-making
$817,124Michele A Basso · University Of Washington · R01 · FY2023 · AG
Aberrant proteomes in tauopathy: revealing functional consequences via multimodal proteomics
$816,661Danielle L Swaney · University Of California, San Francisco · R01 · FY2025 · AG
Regulation Of Intracellular Iron Metabolism
$816,604Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease
$816,403Bruce A Yankner · Harvard Medical School · T32 · FY2018 · AG
Genomic sequencing to establish a macaque genotype and phenotype research resource
$816,254Betsy M Ferguson · Oregon Health & Science University · R24 · FY2022 · OD
Genomic sequencing to establish a macaque genotype and phenotype research resource
$816,254Betsy M Ferguson · Oregon Health & Science University · R24 · FY2021 · OD
Using geroscience to understand and treat Alzheimer's disease
$815,791Pamela Anne Maher · Salk Institute For Biological Studies · R01 · FY2021 · AG
Subjective Cognitive Decline in OIder Adults
$815,640Katherine A. Gifford · Vanderbilt University Medical Center · R01 · FY2023 · AG
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$815,581D. Martin Watterson · Northwestern University At Chicago · U01 · FY2025 · AG